LYRA Lyra Therapeutics Inc

USD 0.38 0.02 4.189336
Icon

Lyra Therapeutics Inc (LYRA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.383

+0.02 (+4.19)%

USD 0.02B

5.86M

USD 6.38(+1,564.49%)

N/A

Icon

LYRA

Lyra Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.38
0.00 0
Take a Tour

Lyra Therapeutics Inc (LYRA) Stock Forecast

Show ratings and price targets of :
USD 6.38
(+1,564.49%)

Based on the Lyra Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Lyra Therapeutics Inc is USD 6.38 over the next 12 months. Lyra Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Lyra Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 8 negative signals. At the last closing, Lyra Therapeutics Inc’s stock price was USD 0.383. Lyra Therapeutics Inc’s stock price has changed by +2.82% over the past week, -92.91% over the past month and -86.02% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...